noscript

News and Announcements

QBiotics Share Offer Oversubscribed by $4.3m

  • Published October 12, 2016 3:30PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Long term Axstra client QBiotics Limited has successfully raised in $16.8 million from its latest round of capital raising. The Company’s Prospectus Share Offer was oversubscribed by $4.3m following high demand from investors. In light of the interest in QBiotics, a Private Placement was also successfully implemented.

The new capital places QBiotics in a strong financial position moving forward with over AU$30 million in the bank. Current emphasis is on finalising product development and market launch preparation of the anticancer drug EBC-46 for the USA and UK veterinary market, and development of QBiotics’ wound healing treatment WH-1 for human diabetic foot ulcers and venous leg ulcers.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now